Patricia L. Allen
Patricia L. Allen occupies the position of Chief Financial Officer at Vividion Therapeutics, Inc. Ms. Allen is also on the board of 7 other companies.
In the past Ms. Allen occupied the position of Chief Financial Officer, Treasurer & VP at Alnylam Pharmaceuticals, Inc., Finance Director of Alkermes, Inc., CFO, Treasurer & Principal Accounting Officer at Zafgen, Inc. and Auditor at Deloitte & Touche LLP.
Patricia L. Allen received an undergraduate degree from Bryant University.
|06/05/2020||5,635||Disposition at $55.9 per share.||314,997|
|06/05/2020||5,635||Derivative/Non-derivative trans. at $25.73 per share.||144,988|
|06/03/2020||6,365||Disposition at $59.14 per share.||376,427|
|06/03/2020||6,365||Derivative/Non-derivative trans. at $25.73 per share.||163,771|
|01/24/2020||700||Disposition at $67.36 per share.||47,152|
|01/24/2020||6,496||Disposition at $66.55 per share.||432,309|
|01/24/2020||17,804||Disposition at $65.93 per share.||1,173,818|
|01/24/2020||25,000||Derivative/Non-derivative trans. at $3.95 per share.||98,750|